BACKGROUND AND PURPOSE: The exact prevalence of WM signal abnormalities in healthy relatives of MS patients and their impact on disease development has not been fully elucidated. The purpose of this study was to compare WM signal abnormality characteristics and the prevalence of radiologically isolated syndrome in healthy control subjects selected randomly from the population with the healthy relatives of patients with MS. MATERIALS AND METHODS: Healthy control subjects (n = 150) underwent physical and 3T MR imaging examinations. Healthy control subjects were classified as non-familial healthy control subjects (n = 82) if they had no family history of MS or as healthy relatives of patients with MS (n = 68) if they had ≥1 relative affected with MS. The presence of radiologically isolated syndrome was evaluated according to the Okuda criteria; dissemination in space on MR imaging and fulfillment of radiologically isolated syndrome criteria were also evaluated according to Swanton criteria. RESULTS: There was a significantly higher total volume of WM signal abnormality in the healthy relatives of patients with MS compared with the non-familial healthy control subjects (P = .024 for signal abnormality ≥3 mm in size and P = .025 for all sizes). Periventricular localization and the number of lesions in all groups (P = .034 and P = .043) were significantly higher in the healthy relatives of patients with MS; 8.8% of the healthy relatives of patients with MS and 4.9% of non-familial healthy control subjects showed ≥9 WM signal abnormalities; 2.9% of subjects in the healthy relatives of patients with MS group and 2.4% of non-familial healthy control subjects fulfilled radiologically isolated syndrome according to the Okuda criteria, whereas 10.3% and 3.7% of subjects fulfilled radiologically isolated syndrome according to the Swanton criteria. In the healthy relatives of patients with MS, smoking was associated with the presence of WM signal abnormalities, whereas obesity was related to the presence of ≥9 WM signal abnormalities and to fulfillment of radiologically isolated syndrome according to the Swanton criteria. CONCLUSIONS: The frequency of WM signal abnormalities and radiologically isolated syndrome is higher in the healthy relatives of patients with multiple sclerosis patients compared with non-familial healthy control subjects.
BACKGROUND AND PURPOSE: The exact prevalence of WM signal abnormalities in healthy relatives of MSpatients and their impact on disease development has not been fully elucidated. The purpose of this study was to compare WM signal abnormality characteristics and the prevalence of radiologically isolated syndrome in healthy control subjects selected randomly from the population with the healthy relatives of patients with MS. MATERIALS AND METHODS: Healthy control subjects (n = 150) underwent physical and 3T MR imaging examinations. Healthy control subjects were classified as non-familial healthy control subjects (n = 82) if they had no family history of MS or as healthy relatives of patients with MS (n = 68) if they had ≥1 relative affected with MS. The presence of radiologically isolated syndrome was evaluated according to the Okuda criteria; dissemination in space on MR imaging and fulfillment of radiologically isolated syndrome criteria were also evaluated according to Swanton criteria. RESULTS: There was a significantly higher total volume of WM signal abnormality in the healthy relatives of patients with MS compared with the non-familial healthy control subjects (P = .024 for signal abnormality ≥3 mm in size and P = .025 for all sizes). Periventricular localization and the number of lesions in all groups (P = .034 and P = .043) were significantly higher in the healthy relatives of patients with MS; 8.8% of the healthy relatives of patients with MS and 4.9% of non-familial healthy control subjects showed ≥9 WM signal abnormalities; 2.9% of subjects in the healthy relatives of patients with MS group and 2.4% of non-familial healthy control subjects fulfilled radiologically isolated syndrome according to the Okuda criteria, whereas 10.3% and 3.7% of subjects fulfilled radiologically isolated syndrome according to the Swanton criteria. In the healthy relatives of patients with MS, smoking was associated with the presence of WM signal abnormalities, whereas obesity was related to the presence of ≥9 WM signal abnormalities and to fulfillment of radiologically isolated syndrome according to the Swanton criteria. CONCLUSIONS: The frequency of WM signal abnormalities and radiologically isolated syndrome is higher in the healthy relatives of patients with multiple sclerosispatients compared with non-familial healthy control subjects.
Authors: Nicola De Stefano; Eleonora Cocco; Marina Lai; Marco Battaglini; Andrea Spissu; Piernicola Marchi; Gianluca Floris; Marzia Mortilla; Maria L Stromillo; Andrea Paolillo; Antonio Federico; Maria Giovanna Marrosu Journal: Ann Neurol Date: 2006-04 Impact factor: 10.422
Authors: F Barkhof; M Filippi; D H Miller; P Scheltens; A Campi; C H Polman; G Comi; H J Adèr; N Losseff; J Valk Journal: Brain Date: 1997-11 Impact factor: 13.501
Authors: G C Ebers; W J Koopman; W Hader; A D Sadovnick; M Kremenchutzky; P Mandalfino; D M Wingerchuk; J Baskerville; G P Rice Journal: Brain Date: 2000-03 Impact factor: 13.501
Authors: Christian Enzinger; Stephen Smith; Franz Fazekas; Gunther Drevin; Stefan Ropele; Thomas Nichols; Timothy Behrens; Reinhold Schmidt; Paul M Matthews Journal: J Neurol Date: 2006-04-10 Impact factor: 4.849
Authors: A E Hensiek; S R Seaman; L F Barcellos; A Oturai; M Eraksoi; E Cocco; L Vecsei; G Stewart; B Dubois; J Bellman-Strobl; M Leone; O Andersen; K Bencsik; D Booth; E G Celius; H F Harbo; S L Hauser; R Heard; J Hillert; K-M Myhr; M G Marrosu; J R Oksenberg; C Rajda; S J Sawcer; P S Sørensen; F Zipp; D A S Compston Journal: Neurology Date: 2007-01-30 Impact factor: 9.910
Authors: Nancy L Sicotte; Rhonda R Voskuhl; Seth Bouvier; Rochelle Klutch; Mark S Cohen; John C Mazziotta Journal: Invest Radiol Date: 2003-07 Impact factor: 6.016
Authors: Zongqi Xia; Sonya U Steele; Anshika Bakshi; Sarah R Clarkson; Charles C White; Matthew K Schindler; Govind Nair; Blake E Dewey; Lauren R Price; Joan Ohayon; Lori B Chibnik; Irene C M Cortese; Philip L De Jager; Daniel S Reich Journal: JAMA Neurol Date: 2017-03-01 Impact factor: 18.302
Authors: Robert Zivadinov; Paul Polak; Ferdinand Schweser; Niels Bergsland; Jesper Hagemeier; Michael G Dwyer; Deepa P Ramasamy; John G Baker; John J Leddy; Barry S Willer Journal: J Head Trauma Rehabil Date: 2018 Sep/Oct Impact factor: 2.710
Authors: Carolyn E Schwartz; Armon Ayandeh; Murali Ramanathan; Ralph Benedict; Michael G Dwyer; Bianca Weinstock-Guttman; Robert Zivadinov Journal: BMC Neurol Date: 2015-08-12 Impact factor: 2.474
Authors: Y Forslin; T Granberg; A Antwan Jumah; S Shams; P Aspelin; M Kristoffersen-Wiberg; J Martola; S Fredrikson Journal: AJNR Am J Neuroradiol Date: 2016-02-04 Impact factor: 3.825
Authors: Zongqi Xia; Charles C White; Emily K Owen; Alina Von Korff; Sarah R Clarkson; Cristin A McCabe; Maria Cimpean; Phoebe A Winn; Ashley Hoesing; Sonya U Steele; Irene C M Cortese; Tanuja Chitnis; Howard L Weiner; Daniel S Reich; Lori B Chibnik; Philip L De Jager Journal: Ann Neurol Date: 2015-12-09 Impact factor: 10.422
Authors: Darin T Okuda; Aksel Siva; Orhun Kantarci; Matilde Inglese; Ilana Katz; Melih Tutuncu; B Mark Keegan; Stacy Donlon; Le H Hua; Angela Vidal-Jordana; Xavier Montalban; Alex Rovira; Mar Tintoré; Maria Pia Amato; Bruno Brochet; Jérôme de Seze; David Brassat; Patrick Vermersch; Nicola De Stefano; Maria Pia Sormani; Daniel Pelletier; Christine Lebrun Journal: PLoS One Date: 2014-03-05 Impact factor: 3.240